162 related articles for article (PubMed ID: 22386032)
21. [Unfortunate decision on hepatitis B vaccination].
Hagstam P; Gröön P
Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292969
[No Abstract] [Full Text] [Related]
22. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies.
Edmunds WJ
Commun Dis Public Health; 1998 Dec; 1(4):221-8. PubMed ID: 9854877
[TBL] [Abstract][Full Text] [Related]
23. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
24. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].
Szucs TD; Smala A; Berger K; Windorfer A
Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102
[TBL] [Abstract][Full Text] [Related]
25. [Child and adolescent hepatitis B vaccination--responsibilities of the public health service].
Nassauer KA
Gesundheitswesen; 1996 Nov; 58(11):616-7. PubMed ID: 9081503
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis-B vaccination.
Phadke A; Kale A
J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
[No Abstract] [Full Text] [Related]
27. Policy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
Puliyel JM
Health Econ; 2004 Nov; 13(11):1147; author reply 1147-8. PubMed ID: 15547938
[No Abstract] [Full Text] [Related]
28. [Immunization and problems of newborns receiving hepatitis B vaccines in countryside].
Li RC
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):241. PubMed ID: 12716529
[No Abstract] [Full Text] [Related]
29. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia.
Levin CE; Nelson CM; Widjaya A; Moniaga V; Anwar C
Bull World Health Organ; 2005 Jun; 83(6):456-61. PubMed ID: 15976897
[TBL] [Abstract][Full Text] [Related]
30. Vaccine uptake rather than disease mitigation seems to be aim of universal hepatitis B vaccination in the UK.
Puliyel J
BMJ; 2013 Sep; 347():f5187. PubMed ID: 24004990
[No Abstract] [Full Text] [Related]
31. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Jacobs RJ; Rosenthal P; Meyerhoff AS
Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of hepatitis B vaccination of prison inmates.
Pisu M; Meltzer MI; Lyerla R
Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
[TBL] [Abstract][Full Text] [Related]
33. Global progress towards universal childhood hepatitis B vaccination, 2003.
Wkly Epidemiol Rec; 2003 Oct; 78(42):366-70. PubMed ID: 14587209
[No Abstract] [Full Text] [Related]
34. National Advisory Committee on Immunization (NACI). Revised guidelines for booster vaccination against hepatitis B.
Can Commun Dis Rep; 1992 Aug; 18(16):121-2. PubMed ID: 1290997
[No Abstract] [Full Text] [Related]
35. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
Rein DB; Weinbaum CM
Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B vaccination follow-up.
McIntyre PG
Lancet; 1995 Jun; 345(8964):1575. PubMed ID: 7791464
[No Abstract] [Full Text] [Related]
37. The United Kingdom's hepatitis B immunisation strategy--where now?
Goldberg D; McMenamin J
Commun Dis Public Health; 1998 Jun; 1(2):79-83. PubMed ID: 9644118
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B vaccination among research participants, Seattle, Washington.
Hagan H; Thiede H; McGough JP; Alexander ER
Am J Public Health; 2002 Nov; 92(11):1756. PubMed ID: 12406801
[No Abstract] [Full Text] [Related]
39. Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
Beutels P; Edmunds WJ; Antoñanzas F; De Wit GA; Evans D; Feilden R; Fendrick AM; Ginsberg GM; Glick HA; Mast E; Péchevis M; Van Doorslaer EK; van Hout BA;
Pharmacoeconomics; 2002; 20(1):1-7. PubMed ID: 11817988
[TBL] [Abstract][Full Text] [Related]
40. [General hepatitis B vaccination--a challenge for public health in the year 2000].
Raeber PA; Vaudaux B; Steffen R
Soz Praventivmed; 1998; 43 Suppl 1():S3-4, S78. PubMed ID: 9833254
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
